GSK

Últimas notícias

Manchetes no idioma original da fonte.

• NUVL Stock Surges 39% Premarket – Why Is GSK Buying This Boston-Based Oncology Company? (abre em uma nova aba)

  Stocktwits · 1 de out. de 2026

• GSK (GSK) reports 4.05B voting rights, with 271M shares held in treasury (abre em uma nova aba)

  Stock Titan · 1 de out. de 2026

• GSK adds liver candidate from Wave RNA partnership (abre em uma nova aba)

  European Biotechnology Magazine · 1 de out. de 2026

• Tyler Reynolds Joins GSK as Director, Digital Medicine (abre em uma nova aba)

  BioBuzz · 1 de out. de 2026

• GSK Stockmann advises Target Global on Health Force investment (abre em uma nova aba)

  ICLG · 1 de out. de 2026

• GSK slides Wednesday, underperforms market (abre em uma nova aba)

  MarketWatch · 30 de set. de 2026

• GSK Taps Wave Life Sciences’ siRNA Program, Triggering $12M Milestone Payment (abre em uma nova aba)

  Genome Web · 30 de set. de 2026

• GSK continues to stock up on Wave's RNA drugs with liver-focused program (abre em uma nova aba)

  Fierce Biotech · 30 de set. de 2026

• Wave to receive $12M milestone from GSK (WVE:NASDAQ) (abre em uma nova aba)

  Seeking Alpha · 30 de set. de 2026

• Wave Life Sciences Announces GSK Advances Hepatology Candidate from SpiNA siRNA Collaboration (abre em uma nova aba)

  Quiver Quantitative · 30 de set. de 2026

• Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development (abre em uma nova aba)

  globenewswire.com · 30 de set. de 2026

• GSK selected a liver candidate for development, triggering $12 million for Wave. (abre em uma nova aba)

  Stock Titan · 30 de set. de 2026

• GSK (LSE:GSK) The Latest Update Raises A Bigger Question (abre em uma nova aba)

  Yahoo Finance · 30 de set. de 2026

• 5 minutes with Tia Vincent, GSK (abre em uma nova aba)

  European Medical Journal · 29 de set. de 2026

• Spotlight On: GSK's HBV hopeful tops FDA's October agenda (abre em uma nova aba)

  firstwordpharma.com · 29 de set. de 2026

• GSK retains ‘buy’ rating at Jefferies as B7H3 cancer programme seen as underappreciated (abre em uma nova aba)

  Proactive financial news · 29 de set. de 2026

• Gates Foundation Extends Funding for AN2 Therapeutics, GSK Research Collab (abre em uma nova aba)

  Contract Pharma · 28 de set. de 2026

• AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK (abre em uma nova aba)

  Business Wire · 28 de set. de 2026

• GSK PLC | British Pharmaceutical & Biotechnology Company (abre em uma nova aba)

  Britannica · 26 de set. de 2026

• Emma Walmsley | Former GSK CEO & British Business Executive (abre em uma nova aba)

  Britannica · 26 de set. de 2026

• GSK reprimanded for lack of transparency in vaccine campaign case (abre em uma nova aba)

  medwatch.com · 25 de set. de 2026

• How splitting from GSK taught Haleon a spin-off is not a finish line (abre em uma nova aba)

  Semafor · 25 de set. de 2026

• GSK Adds Another Cancer Drug in a $750 Million Deal. Is its Oncology Bet Getting Bigger? (abre em uma nova aba)

  Yahoo Finance · 24 de set. de 2026

• GSK Bets on HUTCHMED to Expand its Multi-Billion-Dollar Oncology Opportunity (abre em uma nova aba)

  Yahoo Finance · 24 de set. de 2026

• GSK slammed for ‘grossly misleading’ and ‘totally unacceptable’ behavior (abre em uma nova aba)

  Fierce Pharma · 24 de set. de 2026

• At a listed price of $50.72, GSK (NYSE: GSK) president acquires 9.414 notional shares in her savings plan (abre em uma nova aba)

  Stock Titan · 24 de set. de 2026

• GSK's Jemperli (dostarlimab) accepted for review by Health Canada for patients with dMMR/MSI-H locally advanced rectal cancer (abre em uma nova aba)

  BioSpace · 24 de set. de 2026

• Berenberg Turns Bullish on GSK as its $750 Million Deal Adds to Pipeline Momentum (abre em uma nova aba)

  Yahoo Finance · 24 de set. de 2026

• $3.3 Million in New Philanthropic Commitments for Good Jobs Western North Carolina From The Rockefeller Foundation, John M. Belk Endowment, and NC GSK Foundation (abre em uma nova aba)

  The Rockefeller Foundation · 24 de set. de 2026

• GSK Bets on Long-Acting Biologics and AI to Reshape Respiratory Care (abre em uma nova aba)

  es.tradingview.com · 23 de set. de 2026